ResearcherNanjing University of Chinese MedicineActive in the last 2 years
Yuan Li
Matched on ORCID iD 0000-0002-4552-5180; OpenAlex author ID A5100721498. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers
Papers 3
- Serum High-Density Lipoprotein Cholesterol Concentrations in Pancreatic Ductal Adenocarcinoma and Its Association With Histological Grade in a Chinese Populati… Co-author DOI 10.1177/10732748251316602↗
- Diagnostic Value of Serum D-dimer, CA19-9, and CT Imaging Features in Pancreatic Ductal Adenocarcinoma and Benign Pancreatic Lesions. Co-author DOI 10.7150/jca.111548↗
- Loss of heterozygosity for Kras G12D promotes REDD1-dependent, non-canonical glutamine metabolism in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.bbrc.2020.03.137↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yingying Cao · 2 shared papers, 2025 · strength 0.55
- Paper Diagnostic Value of Serum D-dimer, CA19-9, and CT Imaging Features in Pancreatic Ductal Adenocarcinoma and Benign Pancr… DOI 10.7150/jca.111548↗
- Paper Serum High-Density Lipoprotein Cholesterol Concentrations in Pancreatic Ductal Adenocarcinoma and Its Association With … DOI 10.1177/10732748251316602↗
- Shuai Ren · 2 shared papers, 2025 · strength 0.55
- Paper Diagnostic Value of Serum D-dimer, CA19-9, and CT Imaging Features in Pancreatic Ductal Adenocarcinoma and Benign Pancr… DOI 10.7150/jca.111548↗
- Paper Serum High-Density Lipoprotein Cholesterol Concentrations in Pancreatic Ductal Adenocarcinoma and Its Association With … DOI 10.1177/10732748251316602↗
- Zhongqiu Wang · 1 shared paper, 2025 · strength 0.28
- Kai Guo · 1 shared paper, 2025 · strength 0.27
- Yu Ma · 1 shared paper, 2020 · strength 0.13
- Mingyue Hu · 1 shared paper, 2020 · strength 0.13
- Sunkai Ling · 1 shared paper, 2020 · strength 0.13
- Bo Kong · 1 shared paper, 2020 · strength 0.13
- Peilin Huang · 1 shared paper, 2020 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.